tirzepatide logo Eli Lilly introduces Mounjaro (tirzepatide) for treatment of obesity and type 2 diabetes Tirzepatide + Niacinamide Injection -
Description
Can I stay on my current dose when switching back to a medication I have used before

By 7.5mg, most researchers report consistent weekly weight loss, and by 10mg, the dual receptor activation is driving meaningful metabolic changes

Next step When the page matches your goal, continue into the FormBlends get-started flow so the intake can route you toward the right prescription review path

Eli Lilly and Co

Tirzepatide microdosing for specific populations Different populations face unique challenges with tirzepatide